Biopharma stocks have been among the most popular and well-performing stocks this year. With recent trends in weight loss drugs and clinical advancements in treating illnesses, this market is set for significant advances this year. There’s no better time for investors to look into the companies leading the charge and the stocks expected to perform best. These three biopharma stocks have products capitalizing on the surging demand for the latest, most popular drugs this year. We’ll detail the developments of ...